Wealth Enhancement Advisory Services
BCRX icon

Wealth Enhancement Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Sell
12,322
-3,696
-23% -$28.7K ﹤0.01% 3297
2025
Q4 		$121K Sell
16,018
-5,806
-27% -$42K ﹤0.01% 3393
2025
Q3 		$152K Sell
21,824
-15,942
-42% -$133K ﹤0.01% 3230
2025
Q2 		$338K Buy
37,766
+95
+0.3% +$885 ﹤0.01% 2551
2025
Q1 		$283K Buy
37,671
+20,043
+114% +$162K ﹤0.01% 2489
2024
Q4 		$133K Buy
17,628
+284
+2% +$2.16K ﹤0.01% 2762
2024
Q3 		$132K Buy
17,344
+5,340
+44% +$40.6K ﹤0.01% 2510
2024
Q2 		$74.2K Buy
12,004
+743
+7% +$4.1K ﹤0.01% 2435
2024
Q1 		$57.2K Buy
+11,261
New +$63.3K ﹤0.01% 2335
2023
Q4 		– Sell
-12,554
Closed -$88.9K – 2349
2023
Q3 		$88.9K Buy
+12,554
New +$90.2K ﹤0.01% 2112

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return